FolliculitisNCT05793164
Characterization and Risk Factors of Folliculitis After Hair Transplantation
An observational study of Folliculitis, run by Nanfang Hospital, Southern Medical University at 1 site in China.
Trial summary
We retrospectively reviewed 1317 patients who had undergone HT and completed 9-month follow-up between January 2018 and June 2021 at 4 medical centers. The incidence of postoperative folliculitis and the patient demographics were assessed. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Folliculitis
- How many people
- 1,317 participants
- Where
- 1 siteChina
- Study dates
- 1 Jan 2018to 1 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected.
Who may be able to join
- 1. Healthy adults between the ages of 18 ~ 60
- 2. patients suitable for autologous hair transplantation according to "the standard of hair transplantation"
Who cannot join
- Coagulation disorders, pregnancy and lactation, immunosuppression
- With severe mental and psychological illness, impairment of body image
- All kinds of immune-related alopecia in the progressive active stage
- Patients judged by the investigator to be unsuitable for this study
Trial locations and contacts
1 site in 1 country.
China1 site
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510080
About this study
We retrospectively reviewed 1317 patients who had undergone HT and completed 9-month follow-up between January 2018 and June 2021 at 4 medical centers. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.
Read the detailed description
Postoperative folliculitis is a common complication after hair transplantation (HT) and requires effective preventive interventions. This study aimed to characterize postoperative folliculitis and determine the risk factors in patients underwent HT. The study was conducted at 4 clinical sites: Nanfang Hospital of Southern Medical University, the First Affiliated Hospital, Zhejiang University School of Medicine, the Affiliated Hospital of Guilin Medical University, and Peking University Third Hospital. Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.
- Conditions
- Folliculitis
- Being tested
- no intervention
- Keywords
- folliculitis, hair transplantation, Follicular Unit Extraction
- Medical subject headings
- Folliculitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
no interventionOther
no intervention
| Study group | Role | What they receive |
|---|---|---|
| Patients with postoperative folliculitis | Patients presented folliculitis in surgical-area lesions after hair transplantation within 9-month follow up. Receives: Other: no intervention | |
| patients without postoperative folliculitis | Patients didn't present folliculitis in surgical-area lesions after hair transplantation within 9-month follow up. Receives: Other: no intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
folliculitis
patients present folliculitis after hair transplantation
Measured: 9 months after hair transplantation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Mar 2023
- Study start1 Jan 2018
- Primary completion1 Jun 2021
- Study completion1 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for FolliculitisStudies of the same condition, open and under way.
- More trials run by Nanfang Hospital, Southern Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 1,317 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Zhiqi Hu, PhD, Study chair, Nanfang Hospital, Southern Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05793164
- Sponsor's protocol ID
- NFEC-2020-152
- Status last verified
- Mar 2023
- First submitted
- 20 Mar 2023
- Last updated
- 31 Mar 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Characterization and Risk Factors of Folliculitis After Hair Transplantation
- ClinicalTrials.gov ID
- NCT05793164
- Acronym / sponsor ID
- NFEC-2020-152
- Conditions
- Folliculitis
- Keywords
- folliculitis, hair transplantation, Follicular Unit Extraction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,317 participants (actual)
- Lead sponsor
- Nanfang Hospital, Southern Medical UniversityUniversity, hospital or other
- Study start
- 1 Jan 2018 (actual)
- Primary completion
- 1 Jun 2021 (actual)
- Study completion
- 1 Oct 2022 (actual)
- First posted
- 31 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
We retrospectively reviewed 1317 patients who had undergone HT and completed 9-month follow-up between January 2018 and June 2021 at 4 medical centers. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.
Detailed description
Postoperative folliculitis is a common complication after hair transplantation (HT) and requires effective preventive interventions. This study aimed to characterize postoperative folliculitis and determine the risk factors in patients underwent HT. The study was conducted at 4 clinical sites: Nanfang Hospital of Southern Medical University, the First Affiliated Hospital, Zhejiang University School of Medicine, the Affiliated Hospital of Guilin Medical University, and Peking University Third Hospital. Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patients with postoperative folliculitis | – | Other: no interventionPatients presented folliculitis in surgical-area lesions after hair transplantation within 9-month follow up. |
| patients without postoperative folliculitis | – | Other: no interventionPatients didn't present folliculitis in surgical-area lesions after hair transplantation within 9-month follow up. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected.
Key inclusion criteria (2 listed)
- 1. Healthy adults between the ages of 18 ~ 60
- 2. patients suitable for autologous hair transplantation according to "the standard of hair transplantation"
Key exclusion criteria (4 listed)
- Coagulation disorders, pregnancy and lactation, immunosuppression
- With severe mental and psychological illness, impairment of body image
- All kinds of immune-related alopecia in the progressive active stage
- Patients judged by the investigator to be unsuitable for this study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| no interventionno intervention | Other | Patients with postoperative folliculitis, patients without postoperative folliculitis |
Primary outcome
folliculitis
Time frame: 9 months after hair transplantation
patients present folliculitis after hair transplantation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2023.
Related trials for Folliculitis
Not yet recruitingPhase 2
Biologics in Folliculitis Decalvans : an Adaptative Trial Research
Folliculitis Decalvans (FD)
RecruitingPhase 2
TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis
EGFR Inhibitor-associated Rash
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Zhiqi Hu, PhD study chair
Nanfang Hospital, Southern Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Folliculitis, run by Nanfang Hospital, Southern Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
folliculitis (time frame: 9 months after hair transplantation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2023.